Harindranath

Be the best version of yourself !

[alphaaffairsf2f @alphaaffairsf2f]

Shree refrigerations Ltd

Try to understand below details from the company

One cant afford to miss this, if invested or want to invest in the company

👇👇👇👇👇

[Weekend Trader @ADX_Learner]

Breakout retest stocks:

🔸Nuvama Wealth Management Ltd
🔸Black Box Ltd
🔸Va Tech Wabag Ltd
🔸Jay Bharat Maruti Ltd

Keep👀

[Sunil Gurjar, CFTe @sunilgurjar01]

🚨 𝗦𝗧𝗢𝗖𝗞𝗦 𝗪𝗜𝗧𝗡𝗘𝗦𝗦𝗜𝗡𝗚 𝗛𝗨𝗚𝗘 𝗗𝗜𝗜 𝗕𝗨𝗬𝗜𝗡𝗚 💰🔥

📊 Strong Accumulation by Domestic Institutional Investors

👀 Where Is the Big Domestic Money Flowing?

A Must-Watch [Thread] 🧵

1- JUBLFOOD:- DII Buying 2.85%

[Sunil Gurjar, CFTe @sunilgurjar01]

𝗧𝗼𝗽 𝗕𝗿𝗲𝗮𝗸𝗼𝘂𝘁 𝗔𝗻𝗱 𝗕𝗿𝗲𝗮𝗸𝗼𝘂𝘁 𝗦𝗼𝗼𝗻 𝗦𝘁𝗼𝗰𝗸𝘀 𝗙𝗼𝗿 𝘁𝗵𝗲 𝗡𝗲𝘅𝘁 𝗪𝗲𝗲𝗸 ⬇️

𝗠𝗢𝗥𝗘𝗣𝗘𝗡𝗟𝗔𝗕 : 25-Years Cup & Handle Pattern BO Soon + Volume Buildup

𝗜𝗡𝗗𝗦𝗪𝗙𝗧𝗟𝗔𝗕 : 21-Years Resistance BO + Volume Accumulation

𝗩𝗔𝗥𝗥𝗢𝗖 : 7-Years 3T VCP Pattern BO + Volume Buildup

𝗕𝗛𝗔𝗥𝗔𝗧𝗙𝗢𝗥𝗚 : Tight Range BO + Volume Buildup + MACD Bullish Crossover

𝗣𝗡𝗕 :Bullish Adam & Eve Reversal Pattern BO Soon

𝗟𝗔𝗨𝗥𝗨𝗦𝗟𝗔𝗕𝗦 : Tight Range BO Soon

𝗔𝗨𝗥𝗢𝗣𝗛𝗔𝗥𝗠𝗔 : Basing Pattern BO + Volume Buildup

𝗔𝗩𝗔𝗟𝗢𝗡 : Darvas Box BO + Volume Spurt

𝗪𝗜𝗡𝗗𝗟𝗔𝗦 : 4T VCP Pattern BO Soon + Golden Crossover

𝗜𝗢𝗟𝗖𝗣 : 6-Years Basing Pattern Breakout Soon

𝗦𝗜𝗦 : Descending Triangle Pattern BO Soon + Volume Buildup

[Sunil Gurjar, CFTe @sunilgurjar01]

🚨 𝗛𝗜𝗚𝗛 𝗖𝗢𝗡𝗩𝗜𝗖𝗧𝗜𝗢𝗡 𝗪𝗘𝗘𝗞𝗟𝗬 𝗦𝗧𝗢𝗖𝗞𝗦 🚀

💥 15–25% Upside Potential on a Swing Basis

A Must-Open Thread 🧵🔥

(Bookmark It) 🔖

1- MARINE

[Swing VCP Trader @swingVCP]

🔥Top 08 Stocks Im Tracking for Monday

My Fav 2, 4, 8 & 9

Save it for Later🔖

1. #Paras

[Stoxzy @Stoxzy__]

🚨Top 3 Big Base Weekly Breakout Stocks 📊

20-50% Upside Potential in Positional Basis for the next few months

Super Strong Charts ✅

1) #VARROC - brkout with volume Buildup

[Samir Pradhan @SamirPradhann]

🔥20 Smallcap Stocks with Huge Revenue Guidance for FY27 (30% Above Growth)

Save it for later 🔖

1. HFCL - 40% Revenue Growth in FY27.

2. Syrma SGS - 35% Revenue Growth.

3. Netweb - 35-40% Top line growth

4. Sobha - 30% growth guidance for FY27.

5. MTAR - 80% revenue growth guidance in FY27.

6. RossTech- 80-90% topline growth in FY27.

7. GSM Foils - 55-65% revenue growth in FY27

8. KRN Heat Exchangers - 60% revenue growth in FY-27

9. Cupid - 50% revenue and 70% PAT growth for FY27

10. V2 Retail - 50% revenue growth guidance in FY27

11. Aditya Infotech - 50% revenue growth in FY27

12. Senores Pharma - 30-40% revenue and 50% PAT growth in FY27.

13. Sky Gold - 30-35% revenue growth guidance in FY27

14. TD Power Systems - 30% revenue growth in FY27

15. KMEW - 30% revenue guidance.

16. Krishna Phoschem - 30% revenue growth Guidance for FY27

17. Aeroflex - 35% Revenue growth expected in FY27.

18. Stallion - 30-35% Revenue expected in FY27.

19. Sakar Healthcare - 40% Growth topline and Bottomline in FY27.

20. Man Industries - 43% Growth guidance in FY27.

Which one you have? Comment 👇

[Harindranath @harindranadh1]

Biggest risk in MV Electrosystems?

Execution. A strong order book means little if projects aren't executed on time and at healthy margins. High dependence on railway orders adds another layer of risk.
#MVElectrosystems #ExecutionRisk #IndianRailways #StockMarketIndia

[Gnyanad Bhatt @Asset_Architect]

Neuland Laboratories 22000 💊🧬

One of India’s finest API and CDMO companies.

Unlike many pharma companies that focus on selling finished medicines, Neuland specializes in Active Pharmaceutical Ingredients (APIs), custom manufacturing (CDMO) and complex chemistry for global pharmaceutical innovators.

Think of it this way…

Before a medicine reaches a pharmacy shelf, someone has to manufacture its most critical ingredient.

That’s exactly what Neuland does.

The company partners with global pharma companies to develop and manufacture complex drug substances that are difficult to produce and require years of technical expertise.

Recent Q1 FY27 Results

📈 Revenue: ₹515 Cr (+23% YoY)
📈 EBITDA: ₹147 Cr (+31% YoY)
📈 Net Profit: ₹105 Cr (+35% YoY)
📈 EBITDA Margin: ~28.5%, reflecting strong operating leverage and a better product mix.

Growth was driven by robust demand in both the CMS (Custom Manufacturing Solutions) and Generic API businesses, with continued traction in regulated export markets.

What’s working for them?

✅ One of India’s leading API and CDMO companies with over four decades of chemistry expertise.

✅ Strong presence in complex APIs, where competition is limited and margins are significantly higher.

✅ Long-standing relationships with global innovator pharmaceutical companies.

✅ Expanding manufacturing capacities to meet increasing demand from regulated markets.

✅ A major beneficiary of the China+1 strategy as global pharma companies diversify their supply chains.

Why do I like it?

Many investors focus only on companies that sell medicines.

Neuland is different.

It manufactures the critical drug substances that pharmaceutical companies around the world rely on.

That creates high entry barriers, sticky customer relationships and long-term earnings visibility.

In my opinion, Neuland isn’t just another API company.

It’s a high-quality chemistry business with a growing CDMO franchise and one of the strongest execution records in the Indian pharmaceutical sector.

For investors looking at the next 3–5 years, Neuland Laboratories remains one of the best plays on India’s increasing role in the global pharmaceutical supply chain. 📈

[Harindranath @harindranadh1]

MV Electrosystems:
• FY26 revenue declined sharply.
• Turned loss-making in FY26.
• Negative operating cash flows.
• Heavy dependence on Railway orders.
• High customer concentration risk. • Working capital-intensive business.
#MVElectrosystems #IPO #StockMarketIndia

[Swing VCP Trader @swingVCP]

🔥Top 08 Stocks Im Tracking for Tomorrow

My Fav 4

Save it for Later🔖

1. #Apollo

[Sunil Gurjar, CFTe @sunilgurjar01]

🔥 𝗧𝗼𝗽 𝟳 𝗦𝘁𝗿𝗼𝗻𝗴𝗲𝘀𝘁 𝗦𝘁𝗼𝗰𝗸𝘀 𝗢𝗳 𝗧𝗵𝗲 𝗗𝗮𝘆 📈

Strong Setups💥

Don’t Miss These 👀

A Must-Open [Thread] 🧵

1- ROSSTECH

[Samir Pradhan @SamirPradhann]

🔥Top 06 Breakout Smallcap Stocks.

👉 15 to 30% Upside Potential !

Bookmark it 🔖

1. Minda Corp

[Gnyanad Bhatt @Asset_Architect]

🚨 FRESH Monthly Breakout Retest Watchlist 🚨

A monthly breakout retest is often one of the best long-term entry opportunities.

Instead of chasing price, you let the stock come back to you. The risk-reward shifts in your favour, not the market’s.

💠 Supriya Lifescience
💠 Black Box
💠 NRB Bearings
💠 Siemens
💠 KMC Speciality Hospitals
💠 Orchid Pharma
💠 BHEL
💠 Wheels India
💠 Sandhar Technologies
💠 Adani Ports
💠 Talbros Automotive Components
💠 Angel One
💠 Innova Captab
💠 VA Tech Wabag
💠 Venus Pipes & Tubes

Study them. Add them to your watchlist. The best entries often come on the retest, not the breakout. 📈

[Samir Pradhan @SamirPradhann]

Aether Industries 🔥
Shadowfax Technologies 🔥🔥
Yasho Industries 🔥🔥🔥

Posted Superb Result. ✅

[stoxpilot @StoxPilot]

🔥Stocks Im Tracking for Monday

My fav 1, 3 & 4

Save it for Later🔖

01). #Paras

[Gnyanad Bhatt @Asset_Architect]

RKFORGE ₹640

I shared this around ₹600 back in May.

For almost 90 days, it did absolutely nothing. No excitement. No breakout. Just sideways price action.

This is where most investors lose patience. They get frustrated, exit the stock, and move on.

Now the company has delivered strong Q1 results, management has given bullish growth guidance, the stock has turned green on the weekly chart after 19 months, and it has finally taken out a major monthly supply zone.

The biggest returns rarely come immediately after you buy. They come to those who can sit through the boring phase.

If RKFORGE clears its long-term downtrend, this move could surprise a lot of people.

[Perfect Swing @perfectswing12]

🔥Top 7 Swing & Momentum Stocks

High Priority Breakout Stocks🔥

Chart Purely Educational Purpose Ke Liye Hai. Always Wait For Confirmation Before Taking Any Action

1. #WockhardtPharma

[Dr. AK 🇮🇳 @docakx]

A 21-year-old woman took all 5 anti-rabies injections and rabies immunoglobulin after a dog bite. Still she died of rabies.

Here are the real reasons why the vaccine sometimes fails and what we must fix.

1. Stitching the bite wound